Dr. Benjamin Thomas, MD
What this data tells you about Dr. Thomas
Dr. Benjamin Thomas is an ophthalmology in Jacksonville, FL, with 17 years in practice. Based on federal Medicare data, Dr. Thomas performed 17,671 Medicare services across 4,481 unique beneficiaries.
Between the years covered by Open Payments, Dr. Thomas received a total of $75,639 from 25 pharmaceutical and/or device companies across 234 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Thomas is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) | 5,820 | $28 | $77 |
| Retinal imaging (OCT scan) | 2,517 | $29 | $78 |
| Aflibercept eye injection (Eylea) | 2,134 | $673 | $1,659 |
| Eye injection for retinal disease | 1,500 | $91 | $426 |
| Retinal photography (fundus photo) | 1,115 | $26 | $126 |
| Injection, ranibizumab, 0.1 mg | 886 | $179 | $625 |
| Office visit, established patient (20-29 min) | 708 | $68 | $149 |
| Extended exam of the back part of the eye with optic nerve drawing | 620 | $12 | $80 |
| Comprehensive eye exam, established patient | 515 | $84 | $223 |
| Eye exam, established patient, focused | 431 | $60 | $181 |
| Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 393 | $217 | $984 |
| Injection, dexamethasone, intravitreal implant, 0.1 mg | 308 | $153 | $375 |
| Injection, pegcetacoplan, intravitreal, 1 mg | 255 | $120 | $649 |
| New patient office visit (45-59 min) | 180 | $118 | $331 |
| Compounded drug, not otherwise classified | 83 | $63 | $311 |
| Injection, bevacizumab, 10 mg | 57 | $50 | $304 |
| 2d ultrasound scan of eye tissue and structures | 39 | $35 | $230 |
| New patient office visit, complex (60-74 min) | 26 | $173 | $397 |
| Unclassified drugs | 25 | $1,824 | $5,704 |
| Removal of membrane of retina with removal of internal limiting membrane of retina | 20 | $901 | $3,620 |
| Office visit, established patient (30-39 min) | 20 | $85 | $182 |
| Office visit, established patient, complex (40-54 min) | 19 | $135 | $301 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for ophthalmology in FL.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Thomas is a mixed practice specialist, with above-average Medicare volume (top 8% in FL), and high industry engagement (speaking/promotional, top 5%), with 17 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Thomas experienced with eye injection (vabysmo/faricimab)?
Does Dr. Thomas receive payments from pharmaceutical companies?
How do Dr. Thomas's costs compare to other ophthalmologys in Jacksonville?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology